Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Boi-ogi-to (TJ-20), a Kampo Formula, Suppresses the Inflammatory Bone Destruction and the Expression of Cytokines in the Synovia of Ankle Joints of Adjuvant Arthritic Rats.

Zhang X, Wu Z, Liu Y, Ni J, Deng C, Zhao B, Nakanishi H, He J, Yan X.

Evid Based Complement Alternat Med. 2017;2017:3679295. doi: 10.1155/2017/3679295. Epub 2017 May 7.

2.

Ellagic acid alleviates adjuvant induced arthritis by modulation of pro- and anti-inflammatory cytokines.

Allam G, Mahdi EA, Alzahrani AM, Abuelsaad AS.

Cent Eur J Immunol. 2016;41(4):339-349. doi: 10.5114/ceji.2016.65132. Epub 2017 Jan 24.

3.

Immune modulation of some autoimmune diseases: the critical role of macrophages and neutrophils in the innate and adaptive immunity.

Navegantes KC, de Souza Gomes R, Pereira PAT, Czaikoski PG, Azevedo CHM, Monteiro MC.

J Transl Med. 2017 Feb 15;15(1):36. doi: 10.1186/s12967-017-1141-8. Review.

4.

Mast cell depletion in the preclinical phase of collagen-induced arthritis reduces clinical outcome by lowering the inflammatory cytokine profile.

van der Velden D, Lagraauw HM, Wezel A, Launay P, Kuiper J, Huizinga TW, Toes RE, Bot I, Stoop JN.

Arthritis Res Ther. 2016 Jun 13;18(1):138. doi: 10.1186/s13075-016-1036-8.

5.

Interleukin-10 regulates the inflammasome-driven augmentation of inflammatory arthritis and joint destruction.

Greenhill CJ, Jones GW, Nowell MA, Newton Z, Harvey AK, Moideen AN, Collins FL, Bloom AC, Coll RC, Robertson AA, Cooper MA, Rosas M, Taylor PR, O'Neill LA, Humphreys IR, Williams AS, Jones SA.

Arthritis Res Ther. 2014 Aug 30;16(4):419. doi: 10.1186/s13075-014-0419-y.

6.

Type 1 regulatory T cells specific for collagen type II as an efficient cell-based therapy in arthritis.

Asnagli H, Martire D, Belmonte N, Quentin J, Bastian H, Boucard-Jourdin M, Fall PB, Mausset-Bonnefont AL, Mantello-Moreau A, Rouquier S, Marchetti I, Jorgensen C, Foussat A, Louis-Plence P.

Arthritis Res Ther. 2014 May 22;16(3):R115. doi: 10.1186/ar4567.

7.

Clinical applications of mesenchymal stem cells in chronic diseases.

Farini A, Sitzia C, Erratico S, Meregalli M, Torrente Y.

Stem Cells Int. 2014;2014:306573. doi: 10.1155/2014/306573. Epub 2014 Apr 30. Review.

8.

Korean red ginseng saponin fraction rich in ginsenoside-Rb1, Rc and Rb2 attenuates the severity of mouse collagen-induced arthritis.

Endale M, Im EJ, Lee JY, Kim SD, Yayeh T, Song YB, Kwak YS, Kim C, Kim SH, Roh SS, Cho JY, Rhee MH.

Mediators Inflamm. 2014;2014:748964. doi: 10.1155/2014/748964. Epub 2014 Apr 16.

9.

Fas signaling in macrophages promotes chronicity in K/BxN serum-induced arthritis.

Huang QQ, Birkett R, Koessler RE, Cuda CM, Haines GK 3rd, Jin JP, Perlman H, Pope RM.

Arthritis Rheumatol. 2014 Jan;66(1):68-77. doi: 10.1002/art.38198.

10.

Murine analogues of etanercept and of F8-IL10 inhibit the progression of collagen-induced arthritis in the mouse.

Doll F, Schwager K, Hemmerle T, Neri D.

Arthritis Res Ther. 2013 Sep 27;15(5):R138. doi: 10.1186/ar4319.

11.

Pro-Inflammatory Signaling by IL-10 and IL-22: Bad Habit Stirred Up by Interferons?

Mühl H.

Front Immunol. 2013 Feb 4;4:18. doi: 10.3389/fimmu.2013.00018. eCollection 2013.

12.

Interleukin-22 reduces the severity of collagen-induced arthritis in association with increased levels of interleukin-10.

Sarkar S, Zhou X, Justa S, Bommireddy SR.

Arthritis Rheum. 2013 Apr;65(4):960-71. doi: 10.1002/art.37849.

13.

Blocking proinflammatory cytokine release modulates peripheral blood mononuclear cell response to Porphyromonas gingivalis.

Berker E, Kantarci A, Hasturk H, Van Dyke TE.

J Periodontol. 2013 Sep;84(9):1337-45. doi: 10.1902/jop.2012.120422. Epub 2012 Nov 23.

14.

Disease-dependent local IL-10 production ameliorates collagen induced arthritis in mice.

Henningsson L, Eneljung T, Jirholt P, Tengvall S, Lidberg U, van den Berg WB, van de Loo FA, Gjertsson I.

PLoS One. 2012;7(11):e49731. doi: 10.1371/journal.pone.0049731. Epub 2012 Nov 16.

15.

The p38 MAPK Pathway in Rheumatoid Arthritis: A Sideways Look.

Clark AR, Dean JL.

Open Rheumatol J. 2012;6:209-19. doi: 10.2174/1874312901206010209. Epub 2012 Sep 7.

16.

Macrophages in synovial inflammation.

Kennedy A, Fearon U, Veale DJ, Godson C.

Front Immunol. 2011 Oct 10;2:52. doi: 10.3389/fimmu.2011.00052. eCollection 2011.

17.

Altered influenza virus haemagglutinin (HA)-derived peptide is potent therapy for CIA by inducing Th1 to Th2 shift.

Sun J, Jia Y, Li R, Guo J, Sun X, Liu Y, Li Y, Yao H, Liu X, Zhao J, Li Z.

Cell Mol Immunol. 2011 Jul;8(4):348-58. doi: 10.1038/cmi.2011.5. Epub 2011 Mar 7.

18.

Interleukin-10 repletion suppresses pro-inflammatory cytokines and decreases liver pathology without altering viral replication in murine cytomegalovirus (MCMV)-infected IL-10 knockout mice.

Tang-Feldman YJ, Lochhead GR, Lochhead SR, Yu C, Pomeroy C.

Inflamm Res. 2011 Mar;60(3):233-43. doi: 10.1007/s00011-010-0259-4. Epub 2010 Oct 5.

19.

Immunotherapy for nonalcoholic steatohepatitis using the multiple cytokine production modulator Y-40138.

Tsujimoto T, Kawaratani H, Kitazawa T, Yoshiji H, Fujimoto M, Uemura M, Fukui H.

World J Gastroenterol. 2009 Nov 28;15(44):5533-40.

20.

Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis.

Schwager K, Kaspar M, Bootz F, Marcolongo R, Paresce E, Neri D, Trachsel E.

Arthritis Res Ther. 2009;11(5):R142. doi: 10.1186/ar2814. Epub 2009 Sep 25.

Supplemental Content

Support Center